Biotronik Neuro Rolls Out AI Feature for Spinal Cord Stim

Biotronik Neuro has launched Embrace One Proactive Intelligence, a proprietary artificial intelligence (AI) capability to advance proactive care for patients implanted with the Prospera spinal cord stimulation (SCS) system.

The company collects over 200 data points per patient daily via automatic, objective remote monitoring. The new AI capability analyzes this data to spot early signals that might indicate a patient could benefit from further support or therapy optimization.

Biotronik noted the AI model doesn’t make clinical decisions or adjust therapy. It offers more insight to its Embrace Care Team, a group of clinical specialists who actively monitor patients and provide personalized care between office visits. Since Embrace One uses data already collected through the Prospera SCS, it doesn’t need further effort from patients or healthcare providers.

New real-world data presented at the American Society of Pain and Neuroscience (ASPN) Annual Meeting showed the AI model can identify patients who may benefit from proactive outreach. In a pilot study, it flagged 188 behavioral-pattern instances across 175 patients, prompting responses in 80.9% of cases. Overall, nearly four in five cases led to targeted support from the Embrace One Care Team, including remote reprogramming, therapy optimization, and patient education.

Comments from Biotronik and clinicians

Holger Krumel, group CEO, Biotronik: “BIOTRONIK Neuro is uniquely positioned to bring AI-assisted support to spinal cord stimulation because of the rich, continuously expanding real-world dataset generated through our remote monitoring capabilities. This innovation reflects our longstanding commitment to developing technologies that support patients beyond the clinic. By combining remote monitoring, personalized support, and AI-driven intelligence, we are advancing proactive care and helping SCS patients achieve stable, long-term relief.”

David Dickerson, MD, Endeavor Health, Chicago, Illinois: “This level of support gives me great peace of mind. One of the challenges in managing SCS therapy is that patients don’t always recognize how subtle changes in their behavior may impact pain relief. Proactive Intelligence strengthens the Embrace One Care Team’s ability to identify patients who may benefit from outreach, creating more opportunities to address issues proactively and connect patients with the support they need.”

Biotronik Neuro acquired spinal cord stimulation IP from Soin Neuroscience last week. Learn more here.